Holen Sie sich die Stockscreener-App
13.45
3.79%
-0.53
Handel nachbörslich:
13.45
Schlusskurs vom Vortag:
$13.98
Offen:
$13.79
24-Stunden-Volumen:
6.04M
Relative Volume:
1.38
Marktkapitalisierung:
$6.65B
Einnahmen:
$4.49B
Nettoeinkommen (Verlust:
$-1.26B
KGV:
-67.25
EPS:
-0.2
Netto-Cashflow:
$425.00M
1W Leistung:
-5.75%
1M Leistung:
+3.70%
6M Leistung:
-21.76%
1J Leistung:
+13.79%
1-Tages-Spanne:
$13.30
$13.90
1-Wochen-Bereich:
$13.30
$14.71
52-Wochen-Spanne:
$11.40
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ELAN | 13.45 | 6.65B | 4.49B | -1.26B | 425.00M | -0.20 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - Morningstar
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile – Hagens Berman - GlobeNewswire Inc.
Companion Animal Ear Infection Treatment Market Trends, - openPR
Animal Biotechnology Market to Continue Impressive Measured - openPR
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 6, 2024 in Elanco Animal Health Incorporated LawsuitELAN - PR Newswire
Animal Antibacterial and Antibiotics Market Analysis By Top - openPR
Elanco Faces Class Action Lawsuit Over Zenrelia Safety Claims, Launch Timeline | ELAN Stock News - StockTitan
ELAN FRAUD ALERT: Suffer Losses on Your Elanco Animal - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal - GlobeNewswire
Elanco Animal Health Inc. Class Action: Lead Plaintiff Deadline is December 6, 2024; Contact Robbins LLP for - EIN News
Elanco buys manufacturing facility in England for $25M - Indianapolis Business Journal
Elanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain - Pet Age
Elanco Acquires $180M Revenue UK Facility for $25M, Secures Critical Supply Chain | ELAN Stock News - StockTitan
Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals - Simply Wall St
Elanco Animal Health's (NYSE:ELAN) Promising Earnings May Rest On Soft Foundations - Yahoo Finance
Elanco settles with SEC for $15M over alleged deception - AGDAILY
ELAN COURT ALERT: ELANCO ANIMAL HEALTH (ELAN) Investors that Suffered Losses are Alerted of a Pending Class ActionContact BFA Law before December 6 Court Deadline - AccessWire
Aquaculture Healthcare Market Worth Observing Growth | Elanco, Alltech, Benchmark Holdings - openPR
Europe Veterinary Orthopedics Market Expected to Reach $152 - openPR
Levi & Korsinsky Reminds Elanco Investors of the Pending | Trending From Our Network - Chicago Star Media
Elanco Animal Health Incorporated Investors: Please contact the Portnoy Law Firm to recover - The Bakersfield Californian
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - PR Newswire
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety ... - The Bakersfield Californian
ELAN (Elanco Animal Health) EV-to-Revenue : 2.44 (As of Nov. 14, 2024) - GuruFocus.com
Investors in Elanco Animal Health Incorporated Should Contact The Gross Law Firm Before December 6, 2024 to Discuss Your RightsELAN - PR Newswire
Elanco Animal Health Inc.'s SWOT analysis: stock outlook mixed amid product launches - Investing.com Australia
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit - Morningstar
Elanco settles SEC securities fraud suit for $15 million - FeedStrategy.com
Elanco Advances A Four-Pillar Livestock Sustainability Strategy - Bovine Veterinarian
Elanco Pays $15M SEC Fine To Settle Sales Incentive Claims - Law360
SEC Fines Elanco $15 Million Over Sales Incentive Practices - The Wall Street Journal
ELAN LEGAL ALERT: Elanco Animal Health (ELAN) was Sued for FraudInvestors are Urged to Contact BFA Law by December 6 Court Deadline - AccessWire
Elanco Animal Health Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Elanco Animal Health Incorporated Provides Earnings Guidance for the Fourth Quarter 2024 - Marketscreener.com
Elanco Animal Health to pay $15 mln to settle SEC fraud case - Reuters
Elanco boosts board with biopharma expert Dr. Stacey Ma - Investing.com
Elanco boosts board with biopharma expert Dr. Stacey Ma By Investing.com - Investing.com Nigeria
Elanco Strengthens Board with Gilead Sciences EVP, Biopharma Expert Dr. Stacey Ma | ELAN Stock News - StockTitan
2024-11-12 | ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing
Kirby McInerney LLP Notifies Elanco Animal Health Incorporated (ELAN) Investors of Class Action Lawsuit and Encourages Investors to Contact the Firm - Business Wire
Elanco Animal Health Incorporated Sued for Securities Law ViolationsContact Levi & Korsinsky Before December 6, 2024 to Discuss Your RightsELAN - PR Newswire
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Elanco (ELAN) Hit with Investor Lawsuit Over New Drug – Hagens Berman - GlobeNewswire
2024-11-11 | ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing
Shareholders of Elanco Animal Health Incorporated Should Contact The Gross Law Firm Before December 6, 2024 to Discuss Your RightsELAN - PR Newswire
William Blair Issues Pessimistic Estimate for ELAN Earnings - MarketBeat
Elanco Animal Health Incorporated's (NYSE:ELAN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Yahoo Finance
2024-11-10 | ELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing
Elanco Animal Health (NYSE:ELAN) Issues Earnings Results - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Q3 2024 Earnings Call Transcript - Insider Monkey
ELAN LAWSUIT ALERT: Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline - The Malaysian Reserve
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):